REFERENCES
- Balat A, Alasehirli B, Oguzkan S, Gungor M. Nitric oxide synthase gene polymorphisms in children with primary nocturnal enuresis: A preliminary study. Renal Failure. 2007; 29: 79–83
- Tanus-Santos JE, Casella-Filho A. Endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: Genotype versus haplotype analysis. Hypertension. 2007; 49: E1
- Sandrim VC, de Syllos RWC, Lisboa HR, Tres GS, Tanus-Santos JE. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis. 2006; 189: 241–246
- Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE. Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis. 2006; 186: 428–432
- Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno Jr H, Tanus-Santos JE. Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens. 2006; 24: 2393–2397
- Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase (eNOS) genetic polymorphisms. Nitric Oxide. 2005; 12: 177–182
- Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001; 11: 719–725